Rafael Holdings RFL
NYSE RFL
$1.53 +0.03 (+2.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rafael Holdings (RFL) Return on Sales [ROS] (2017 - 2026)

Updated

Rafael Holdings (RFL) reported Return on Sales [ROS] of -3837.99% for fiscal Q3 2026 (quarter ended Apr 30, 2026), down 2204.56 percentage points from -1633.43% a year earlier and down 683.96 percentage points from the prior quarter.

Analysis

Rafael Holdings (RFL) Return on Sales [ROS] (2017 - 2026) Analysis & Trends

Over the twelve months ended Apr 30, 2026, Rafael Holdings' Return on Sales [ROS] came in at -3717.24%, down 952.08 percentage points year-over-year; for FY2025 (ended Jul 31, 2025), it came in at -3179.83%, up 12931.16 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of -3007.42 percentage points (FY2020 to FY2025).
  • By fiscal year, Return on Sales [ROS] came in at -16110.99% in FY2024 (-10719.23 pp), -5391.76% in FY2023 (+9358.73 pp), -14750.49% in FY2022 (-11234.40 pp) and -3516.08% in FY2021 (-3343.68 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of -27726.49% in fiscal Q3 2024 and a high of -1633.43% in fiscal Q3 2025.
  • Year over year, Return on Sales [ROS] gained in four of the last eight quarters, with an average year-over-year change of +3121.05 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was fiscal Q3 2025 (a gain of 26093.06 percentage points); the low point was fiscal Q1 2022 (a drop of 25699.56 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -3154.03% (Q2 2026), -4225.42% (Q1 2026) and -3646.57% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Rafael Holdings 78.35 Mn 83.76 Mn 163,000.00 -3,837.99%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -3,837.99%
Jan 31, 2026 -3,154.03%
Oct 31, 2025 -4,225.42%
Jul 31, 2025 -3,646.57%
Apr 30, 2025 -1,633.43%
Jan 31, 2025 -8,622.08%
Oct 31, 2024 -3,003.13%
Jul 31, 2024 -2,330.30%
Apr 30, 2024 -27,726.49%
Jan 31, 2024 -4,622.06%
Oct 31, 2023 -3,644.12%
Jul 31, 2023 -3,839.71%
Apr 30, 2023 -4,269.01%
Jan 31, 2023 -6,084.29%
Oct 31, 2022 -7,345.71%
Jul 31, 2022 -7,011.59%
Apr 30, 2022 -6,171.05%
Jan 31, 2022 -2,160.81%
Oct 31, 2021 -25,936.13%
Jul 31, 2021 -3,516.08%
API Access

Rafael Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=RFL&period=max&api_key=YOUR_API_KEY